“…These were hydroxypropyl-α-CD [23], sulphated-α-CD [21], (2-carboxy-ethyl)-β-CD [34], heptakis(2,3-di- O -acetyl)-β-CD [35], heptakis(2,6-di- O -methyl)-β-CD, heptakis-(2,3,6-tri- O -methyl)-β-CD [36,37], heptakis(2- O -methyl-3,6-di- O -sulfo)-β-CD, heptakis(2,3-di- O -methyl-6- O -sulfo)-β-CD, heptakis(2,3-di- O -acetyl-6- O -sulfo)-β-CD [36], heptakis-6-sulfato-β-CD [38], heptakis-(6- O -sulfobutylether)-β-CD sodium salt [39], heptakis (2,6-di- O -[2-hydroxy-3-(sulfo-amino)propoxy])-β-CD [40], 2-hydroxypropyl-β-CD [37] octa(6- O -sulfo)-γ-cyclodextrin [41], lysine-bridged hemispherodextrin [42], methylated β-CD [43], mono-6-deoxy-6-(4-amino-1,2,4-triazolium)-β-CD chloride [44], mono-6-deoxy-6-(3-methylimidazolium)-β-CD tosylate [45], quaternary ammonium β-CD [46], carboxymethyl-β-CD [47,48], hydroxypropyl-γ-CDs [21,34], sulphated-γ-CDs [21] and highly sulphated-γ-CDs [49]. Sulfobutylether-β-CDs are also available commercially as Captisol ® and were applied successfully in the enantiomeric separation of neutral and basic drugs, but not towards negatively charged analytes in EKC [50].…”